Cidara Therapeutics, Inc(NASDAQ:CDTX) 
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel long-acting anti-infectives for the treatment and prevention of diseases in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the...
Website: http://www.cidara.com
Founded: 2012
Full Time Employees: 68
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 17.20
H 17.20
L 16.10
C 16.43
V 119,539
10EMA 16.43
20EMA 16.43
60EMA 16.43
120EMA 16.43
250EMA 16.43